Markets
PLX

Protalix BioTherapeutics (PLX) Jumps: Stock Rises 8.7%

Protalix BioTherapeutics, Inc.PLX was a big mover last session, as its shares rose almost 9% on the day. The upside was driven by the news of Pfizer PFE building its position in Protalix. This also led to far more shares changing hands than in a normal session. Yesterday's rally breaks the trend for the company since Oct 12, as the stock is now trading above the volatile price range of $0.98 to $1.11.

Over the last 30 days, the company witnessed one positive estimate revision and the Zacks Consensus Estimate also moved higher, suggesting more solid trading ahead. So make sure to keep an eye on this stock going forward to see if Friday's jump can turn into more strength down the road.

Protalix BioTherapeutics currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Is PLX going up? Or down? Predict to see what others think: Up or Down

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

PROTALIX BIOTHR (PLX): Free Stock Analysis Report

PFIZER INC (PFE): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

PLXPFE

Other Topics

Investing Stocks

Latest Markets Videos

Zacks

Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com.

Learn More